Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)

Bo Diao1, Chenhui Wang2, Yingjun Tan1, Xiewan Chen3, Ying Liu4, Lifen Ning5, Li Chen1, Min Li1, Yueping Liu1, Gang Wang1, Zilin Yuan1, Zeqing Feng2, Yi Zhang2, Yuzhang Wu2, Yongwen Chen2
1Department of Medical Laboratory Center, General Hospital of Central Theater Command, Wuhan, China
2Institute of Immunology PLA, Third Military Medical University, Chongqing, China
3Medical English Department, College of Basic Medical Sciences, Army Medical University, Chongqing, China
4Department of Medical Laboratory Medicine, General Hospital of Central Theater Command, Wuhan, China
5Hanyang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China

Tóm tắt

Từ khóa


Tài liệu tham khảo

Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N Engl J Med, 382, 727, 10.1056/NEJMoa2001017

Li, 2020, Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia, N Engl J Med, 382, 1199, 10.1056/NEJMoa2001316

Lu, 2020, Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet, 395, 565, 10.1016/S0140-6736(20)30251-8

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5

Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7

Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA, e201585, 10.1001/jama.2020.1585

The Latest Situation of Novel Coronavirus Pneumonia as of 24:00 on 20 March 2020

Li, 2008, T cell responses to whole SARS coronavirus in humans, J Immunol, 181, 5490, 10.4049/jimmunol.181.8.5490

The Notice of Launching Guideline on Diagnosis and Treatment of the Novel Coronavirus Pneumonia (NCP)

NinaP MarkS Anh-HueTT BrianMF OhilipL Characteristics of Infectious Disease2016

Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7

Wherry, 2015, Molecular and cellular insights into T cell exhaustion, Nat Rev Immunol, 15, 486, 10.1038/nri3862

Mescher, 2006, Signals required for programming effector and memory development by CD8+ T cells, Immunol Rev, 211, 81, 10.1111/j.0105-2896.2006.00382.x

Zhu, 2010, Differentiation of effector CD4 T cell populations (*), Annu Rev Immunol, 28, 445, 10.1146/annurev-immunol-030409-101212

Ng, 2013, Networking at the level of host immunity: immune cell interactions during persistent viral infections, Cell Host Microbe, 13, 652, 10.1016/j.chom.2013.05.014

Fenwick, 2019, T-cell exhaustion in HIV infection, Immunol Rev, 292, 149, 10.1111/imr.12823

Wang, 2008, The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome, Am J Emerg Med, 26, 711, 10.1016/j.ajem.2007.10.031

Matthay, 2012, The acute respiratory distress syndrome, J Clin Invest, 122, 2731, 10.1172/JCI60331

Channappanavar, 2017, Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology, Semin Immunopathol, 39, 529, 10.1007/s00281-017-0629-x

Huang, 2005, An interferon-gamma-related cytokine storm in SARS patients, J Med Virol, 75, 185, 10.1002/jmv.20255

2008, Update on avian influenza A (H5N1) virus infection in humans, N Engl J Med, 358, 261, 10.1056/NEJMra0707279

Chen, 2013, Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome, Lancet, 381, 1916, 10.1016/S0140-6736(13)60903-4

Aggarwal, 1999, Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases, J Immunol, 162, 2154, 10.4049/jimmunol.162.4.2154

Gupta, 2005, Role of NF-kappaB signaling pathway in increased tumor necrosis factor-alpha-induced apoptosis of lymphocytes in aged humans, Cell Death Differ, 12, 177, 10.1038/sj.cdd.4401557

Gabay, 2006, Interleukin-6 and chronic inflammation, Arthritis Res Ther, 8, S3, 10.1186/ar1917

Jones, 2018, Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer, Nat Rev Immunol, 18, 773, 10.1038/s41577-018-0066-7

Burmester, 2016, Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial, Ann Rheum Dis, 75, 1081, 10.1136/annrheumdis-2015-207628

Yokota, 2016, Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan, Ann Rheum Dis, 75, 1654, 10.1136/annrheumdis-2015-207818

Le, 2018, FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome, Oncologist, 23, 943, 10.1634/theoncologist.2018-0028

Kany, 2019, Cytokines in inflammatory disease, Int J Mol Sci, 20, 6008, 10.3390/ijms20236008

Minciullo, 2016, Inflammaging and anti-inflammaging: the role of cytokines in extreme longevity, Arch Immunol Ther Exp, 64, 111, 10.1007/s00005-015-0377-3

Yang, 2013, Expression of B and T lymphocyte attenuator (BTLA) in macrophages contributes to the fulminant hepatitis caused by murine hepatitis virus strain-3, Gut, 62, 1204, 10.1136/gutjnl-2012-302239

Li, 2017, VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism, Nat Commun, 8, 1322, 10.1038/s41467-017-01327-4

McLane, 2019, CD8 T cell exhaustion during chronic viral infection and cancer, Ann Rev Immunol, 37, 457, 10.1146/annurev-immunol-041015-055318

Brooks, 2006, Interleukin-10 determines viral clearance or persistence in vivo, Nat Med, 12, 1301, 10.1038/nm1492

Ejrnaes, 2006, Resolution of a chronic viral infection after interleukin-10 receptor blockade, J Exp Med, 203, 2461, 10.1084/jem.20061462

Wang, 2020, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res, 30, 269, 10.1038/s41422-020-0282-0

Holshue, 2020, First Case of 2019 novel coronavirus in the United States, N Engl J Med, 382, 929, 10.1056/NEJMoa2001191

Diao, 2020, Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19), medRxiv, 10.1101/2020.02.18.20024364